Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Regular Payout of Inc Dist cum Cap Wdrl

Add To Compare

previously known as Tata India Pharma & Healthcare Reg DP until

NAV on March 27, 2026
Category Equity:
Sector - Healthcare
Investment StyleBox
Mid Growth
Total Assets 1,301 cr
Turnover Ratio 11.18%
Expense Ratio 2.11%
Exit Load 0.25%if redeemed within
30 Days
0.00%if redeemed after 30 Days
Returns
  • 1M: -5.31%
  • 1Y: -0.28%
  • 3M: -6.04%
  • 3Y: 21.88%
  • 6M: -5.16%
  • 5Y: 14.65%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since over 1 year)
ISIN INF277K017A7
Fund Family Tata
P/E Ratio 41.15
P/B Ratio 6.83
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha -0.48
Beta 0.95
R-Squared 94.80
Info Ratio -0.45
Tracking Err 3.78
Sortino 1.831
Sharpe 1.037
Std Dev 16.138
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 3.42%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 96.58%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

View Factsheet

-
Best Sector Healthcare Funds
NAME LATEST
NAV
RETURNS
1y    
FUND
ASSETS
Expense
RATIO
RISK
43.153 6.85% 2,844 cr 0.47% -
312.389 3.98% 1,107 cr 1.29% -
485.843 3.64% 4,077 cr 0.91% -
40.320 3.12% 6,801 cr 1.04% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata